FDA panel discusses COVID-19 vaccines

While demand for vaccinations has dropped, the CDC estimates 30,000 to 50,000 adults have died from COVID-19 since October.

WASHINGTON (AP) — Government advisers were meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into question who may be eligible for shots.

The Food and Drug Administration’s outside experts have met regularly since the launch of the first COVID-19 vaccines to discuss tweaking their recipes to stay ahead of the virus. Thursday’s meeting is the group’s first since President Donald Trump took office.

But it comes just two days after FDA leaders upended the prior U.S. policy of recommending annual COVID-19 boosters for all Americans ages 6 months and older.

Already a subscriber? Log in

Username or Email Address

Password

Remember Me

View subscription options